Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Mimedx (MDXG) Accumulated Depreciation & Amortization (2016 - 2025)

Mimedx's Accumulated Depreciation & Amortization history spans 14 years, with the latest figure at $22.4 million for Q2 2025.

  • For Q2 2025, Accumulated Depreciation & Amortization changed N/A year-over-year to $22.4 million; the TTM value through Jun 2025 reached $22.4 million, changed N/A, while the annual FY2024 figure was $21.3 million, 6.46% up from the prior year.
  • Accumulated Depreciation & Amortization for Q2 2025 was $22.4 million at Mimedx, up from $21.9 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $37.3 million in Q2 2023 and bottomed at $20.0 million in Q4 2023.
  • The 5-year median for Accumulated Depreciation & Amortization is $21.9 million (2025), against an average of $25.9 million.
  • The largest annual shift saw Accumulated Depreciation & Amortization grew 11.46% in 2021 before it plummeted 44.25% in 2023.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $32.9 million in 2021, then increased by 9.27% to $35.9 million in 2022, then tumbled by 44.25% to $20.0 million in 2023, then grew by 6.46% to $21.3 million in 2024, then increased by 5.21% to $22.4 million in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Accumulated Depreciation & Amortization are $22.4 million (Q2 2025), $21.9 million (Q1 2025), and $21.3 million (Q4 2024).